Cronos Group completed its acquisition of CanAdelaar B.V. on 15 October 2026, taking full ownership of a Dutch licensed greenhouse producer operating within the Netherlands’ regulated cannabis supply-chain experiment. The Canadian company paid a base consideration of €57.5 million, subject to closing and post-closing adjustments, with additional performance-linked payments possible.
The closing is a distinct milestone from the share purchase agreement announced in December 2025. The completion makes CanAdelaar a wholly owned Cronos subsidiary, according to the buyer’s US securities filing.
Greenhouse scale behind the transaction
CanAdelaar operates in Voorne aan Zee in the Netherlands. In its 15 October completion announcement, Cronos described the business as operating a 540,000-square-foot facility (approximately 50,000 square metres) that covers greenhouse cultivation as well as processing, production and packaging. That figure describes the combined facility, not a separately verified crop-growing area.
The operation is one of ten licensed producers in the country’s Wietexperiment, a controlled supply-chain programme for adult-use cannabis. Cronos says CanAdelaar is the programme’s only large-scale greenhouse cultivator; other licensed operators use indoor production facilities. The company also claims the largest share of sales within the programme, based on its own market survey. That market-share estimate is not an independently audited industry statistic.
CanAdelaar’s own announcement says its existing Dutch management team will continue to run daily operations, with founder Christopher Martens taking the role of general manager of Cronos Netherlands.
Purchase price has a variable component
The €57.5 million base amount is not necessarily the final total transaction cost. The filed terms provide for adjustments and additional cash payments linked to half of CanAdelaar’s normalised EBITDA for each of 2026 and 2027. The final adjusted consideration therefore cannot yet be stated as a single fixed figure.
The Dutch programme restricts the movement and sale of regulated products to its authorised supply chain. It does not establish a general right to export products from the acquired greenhouse into other European markets. Any wider commercial expansion would depend on changes in the relevant regulatory frameworks, rather than following automatically from this acquisition.
What the acquisition changes
For greenhouse-sector investors and suppliers, the immediate development is a change in ownership and capital backing of an established production facility, not an announced new greenhouse build. Cronos gains a Dutch production and processing base; CanAdelaar continues operating within the existing national experiment. Future performance will depend on the integration, the plant’s operations, the programme’s rules and the eventual contingent purchase-price calculations.
Key takeaways
- Cronos closed its acquisition of CanAdelaar on 15 October 2026, following the December 2025 agreement.
- The €57.5 million base price may rise or change through adjustments and EBITDA-linked consideration.
- The 540,000-square-foot figure covers cultivation and other operations; no new greenhouse-construction milestone was announced.
